New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and even performed worse than an older range of treatments called triptans, said a massive global analysis Thursday.
Migraines are severe, often disabling headaches which affect at least one in seven adults globally, according to the World Health Organization. They are also up to three times more common in women than men.
